De-Risking Investments in Medical Technology Innovation by Luigi Negri

DATE

31 March 2026
5:00 – 6:30 pm

VENUE

MIB Trieste School of Management

FORMAT

In person.
In English.

MIB Trieste School of Management will host on March 31st at 5:00 PM the launch event of "De-Risking Investments in Medical Technology Innovation: Strengthening Decision-Making and Valuation Accuracy in Medical Startups", authored by Luigi Negri.

Scientific technologies are evolving at an unprecedented pace — from medicine to artificial intelligence, advanced materials to climate tech.
Yet the way we evaluate startups and innovation hasn't kept up.
In this landscape, making sound decisions under deep uncertainty has become one of the defining challenges for investors, entrepreneurs, and managers working in deep tech.
 
This is the question at the heart of De-Risking Investments in Medical Technology Innovation by Luigi Negri — a book that will be presented at MIB Trieste School of Management in an open, interactive discussion format.
 

The Book
 

The volume offers a structured, evidence-based approach to improving investment decision quality in startups, starting from MedTech — one of the most complex and uncertainty-driven sectors.
At its core:

• the quality of assumptions matters more than the sophistication of financial models
• identifying and managing key sources of uncertainty
• using decision-making frameworks to assess complex innovations

An approach that, while rooted in MedTech, extends across the broader STEM innovation ecosystem.

Event Format: Oxford-Style Debate
 

The book launch will take the form of an Oxford debate, designed to spark a direct conversation on one of innovation's most contested questions: what truly drives startup success?

• On one side, Luigi Negri, the book's author, will argue that decision-making quality and the ability to navigate uncertainty are the real determining factors.
• On the other, Tim Baxter (Director of the MBA in International Business) will put forward an alternative view — that leadership remains the single most critical ingredient for startup success.

The debate will be moderated by Guido Bortoluzzi, MIB faculty member, and is aimed in particular at founders, researchers, investors, and managers with an interest in STEM innovation.

The Author
 

Luigi Negri is Managing Partner at Thinkeen® Global Consulting and Partner at Obloo Ventures. An international specialist in MedTech startup valuation, strategy, and commercialization, he has been advising founders and life sciences companies worldwide since 2013. He has held General Management and commercial leadership roles at CR Bard, Baxter, and LivaNova, operating across Europe, Russia, Latin America, and emerging markets. Recognized by Forbes for his commercial achievements and a member of the Forbes Council (USA), Luigi brings together industrial vision and analytical rigor in investment evaluation.

How to Attend

The event is free and open to the public.
Registration is kindly requested.